Health Scrutiny: Global Updates from Trump's Physical to Big Pharma Moves

The latest health news includes Donald Trump’s upcoming physical at Walter Reed amid public health scrutiny. China's pharma industry remains unaffected by Beijing's tech deal regulations. Eli Lilly's acquisition signals focus on infectious diseases, while FDA regulation changes boost Big Tobacco. Uganda combats rising Ebola cases amidst regional challenges.

In current health news updates, former U.S. President Donald Trump, nearing 80 years old, is set to undergo a routine physical at Walter Reed National Military Medical Center. This follows a year marked by public attention on minor health conditions. Trump positions himself as more vigorous compared to his predecessor, Joe Biden.

Meanwhile, the CEO of JW Therapeutics assured that Beijing's scrutiny over tech deals doesn't affect China's pharmaceutical sector. Global drugmakers are increasingly eyeing experimental medicines from China to cut costs. Analysts predict a record surge in biotech licensing deals this year.

Eli Lilly announced a near $4 billion investment in acquiring three vaccine developers, emphasizing its intent to enter the infectious disease prevention sector. Concurrently, FDA regulatory adjustments may flood the market with new vaping products, reflecting a significant shift under past Trump administration strategies.